Description

Erythropoietin Injection 4000 IU is a recombinant human erythropoietin used to treat anemia associated with chronic kidney disease, HIV infection, and cancer chemotherapy.

Prescription

• Prescription-only medicine (POM)

Dosage

•  Initial dose: 50-100 IU/kg body weight administered intravenously or subcutaneously three times a week.
•  Maintenance dose: Adjusted based on individual patient response.

Therapeutic Category

• Erythropoiesis-stimulating agent, Anaemia treatment

Active Ingredients/Composition

• Recombinant human erythropoietin 4000 IU

Variant

• Erythropoietin Injection 1000 IU, Erythropoietin Injection 2000 IU

Consume Type

• Parenteral administration (intravenous or subcutaneous injection)

Directions/Usage

•  Administer by a healthcare professional.
•  Inject intravenously or subcutaneously as prescribed.

Common Side Effects

•  Hypertension
•  Headache
•  Fatigue
•  Nausea
•  Vomiting
•  Diarrhea
•  Allergic reactions (rare)

Package Type

• Single-use vials or pre-filled syringes

Storage Advice

•  Store in a refrigerator at 2-8°C (36-46°F).
•  Protect from direct sunlight and heat sources.

Safety Advice

•  Use as directed.
•  Monitor blood pressure and hemoglobin levels regularly.
•  Consult healthcare professional before use in patients with hypertension, cardiovascular disease, or seizure disorders.

Product Substitutes

•  Other erythropoiesis-stimulating agents (e.g., darbepoetin alfa)
•  Other anemia treatments (e.g., iron supplements, vitamin B12 injections)

Manufacturer/Marketer

•  Name: Various manufacturers (e.g., Amgen, Johnson & Johnson)
• Reputation: Reputable pharmaceutical companies

Country of Origin

•  USA, UK, Germany